0001209191-17-064686.txt : 20171208 0001209191-17-064686.hdr.sgml : 20171208 20171208160718 ACCESSION NUMBER: 0001209191-17-064686 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170719 FILED AS OF DATE: 20171208 DATE AS OF CHANGE: 20171208 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kelley Susan L. CENTRAL INDEX KEY: 0001519612 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36395 FILM NUMBER: 171247199 MAIL ADDRESS: STREET 1: C/O ARQULE, INC. STREET 2: 19 PRESIDENTIAL WAY CITY: WOBURN STATE: MA ZIP: 01801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Dare Bioscience, Inc. CENTRAL INDEX KEY: 0001401914 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 204139823 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11119 NORTH TORREY PINES ROAD STREET 2: SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-769-9145 MAIL ADDRESS: STREET 1: 11119 NORTH TORREY PINES ROAD STREET 2: SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 FORMER COMPANY: FORMER CONFORMED NAME: Cerulean Pharma Inc. DATE OF NAME CHANGE: 20090714 FORMER COMPANY: FORMER CONFORMED NAME: Tempo Pharmaceuticals Inc DATE OF NAME CHANGE: 20070604 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2017-07-19 2017-07-21 0 0001401914 Dare Bioscience, Inc. DARE 0001519612 Kelley Susan L. C/O DARE BIOSCIENCE, INC. 11119 NORTH TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037 1 0 0 0 Option to Purchase Common Stock 6.56 2017-07-19 4 A 0 2000 0.00 A 2027-07-19 Common Stock 2000 2000 D The exercise price reported reflects the 10 for 1 reverse stock split effected by the Corporation on July 20, 2017. Dr. Kelley was awarded options to purchase shares of the Corporation's common stock in connection with her service as a member of the Board of Directors (the "Director Options") pursuant to the Corporation's 2014 Stock Incentive Plan. The Director Options will vest in full on the earlier of the one year anniversary of the date of grant or immediately prior to the Corporation's 2018 annual meeting of stockholders. This form amends a Form 4 previously filed for Dr. Kelley on July 21, 2017, to correct the description of the vesting schedule of the stock options. /s/ Sebastian E. Lucier, Attorney-in-fact 2017-12-08